Induction chemotherapy followed by radical surgery in cervical cancer

Gynecologic Oncology
P R DottinoC J Cohen

Abstract

To evaluate the therapeutic potential of cytotoxic therapy in patients with squamous cell carcinoma of the cervix, 28 patients with disease clinically localized to the pelvis were treated with chemotherapy followed by radical pelvic surgery. Treatment consisted of cis-platinum 50 mg/m2, mitomycin C 10 mg/m2, vincristine 1.0 mg/m2, and bleomycin 10 U IM given as a course (over 21 days) of induction chemotherapy followed by radical hysterectomy and pelvic and aortic lymphadenectomy in 26 patients and total pelvic exenteration in 2 patients. The stage distribution of the patients in the study was 4 stage IB, 6 stage IIA, 7 stage IIB, 1 stage IIIA, 11 stage IIIB, and 1 stage IVA. Two patients with stage IIIB cancer were found, at the time of laparotomy, to have carcinomatosis and were excluded from the final evaluation in this study. All patients achieved a clinical and histologic response to chemotherapy. There were 35% complete and 65% partial responses. After chemotherapy, at the time of surgery, 4 patients were found to be histologically free of disease, and the incidence of surgically documented nodal disease after chemotherapy was found to be 32%. There was no significant hematologic or pulmonary toxicity. Induction chemother...Continue Reading

Citations

Jul 1, 1995·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·S J Kim
Jan 1, 1995·La Revue de médecine interne·D Zylberait
Sep 16, 2003·Cancer Treatment Reviews·David H Moore
Jun 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P Benedetti-PaniciS Mancuso
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·D. GallardoJ. De La Garza
May 1, 1996·Obstetrical & Gynecological Survey·D Z Edelmann, S O Anteby
Dec 24, 2003·The Cancer Journal·Jeanne M Schilder, Frederick B Stehman
Jul 2, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·T SaitoR Kudo
Sep 1, 1996·British Journal of Obstetrics and Gynaecology·P L GiacaloneB Hedon
Jun 26, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·T MoriH Honjo
Nov 16, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Roberto AngioliPierluigi Benedetti-Panici
Mar 18, 1999·Hematology/oncology Clinics of North America·K GrevenR Lanciano
Jun 5, 2003·Expert Opinion on Pharmacotherapy·David H Moore
May 1, 1997·Gynecologic Oncology·E SerurJ C Remy
Mar 10, 2001·Cancer Treatment Reviews·W T Bradner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.